Xiaolu Sun

Director at IVIEW Therapeutics

Capital raised by IVIEW Therapeutics

$9.2M+$9.2M latest round

2 Form D filings · first filed May 2024 · Cranbury, NJ

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 2
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 1 ↗

Career

1 company on file

IVIEW TherapeuticsBiotech · Cranbury, NJsince May 2024

Director

Listed on IVIEW Therapeutics's Form D filings

Company filings

via EDGAR · Form D for IVIEW Therapeutics2

DateCompanyFormAmountRole on filing

May 14, 2024IVIEW TherapeuticsForm D/A+$9.2M—

Form D/AMay 14, 2024 · IVIEW Therapeutics+$9.2Mnot a signer

May 14, 2024IVIEW TherapeuticsForm D/A+$7.7M—

Form D/AMay 14, 2024 · IVIEW Therapeutics+$7.7Mnot a signer

Overview

Last filing May 14, 2024

Xiaolu Sun is on file as Director at IVIEW Therapeutics in Cranbury, NJ. IVIEW Therapeutics has 2 Form D filings on record, $9.2M raised in total.

Teammates

IVIEW Therapeutics · 1

Bo LiangChief Executive OfficerSigner

Products

IVIEW Therapeutics · 1

IVW-1001Ocular treatment

IVW-1001 is a novel TRPM8 agonist specifically designed for the treatment of dry eye disease. This innovative product is delivered via an ophthalmic eyelid wipe, ensuring both ease of use and targeted action directly at the affected area.